13F filer · CIK 1422849 ↗
Capital World Investors
You are looking at Q1 2026. See the latest, Q2 2026 →
Reported value
$732.94B
−0.3% on the quarter before
Positions
620
110 new · 64 sold out
Top 10
27.7%
of the value
Est. gain
−$27.96B
on stocks held all quarter
Est. return
−4.2%
on those stocks since Q4 2025
Positions as of Mar 31, 2026, from Capital World Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 44% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2025. Striped tiles are options.
Largest buys
Since Q4 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Astrazeneca Plc~$5.52BNew · 0.0% → 0.8%+28,264,580 shares
- Alphabet~$4.56BAdded · 1.2% → 1.8%+15,913,045 shares
- Totalenergies Se~$3.87BAdded · 0.1% → 0.6%+41,917,302 shares
- Amazon~$3.47BAdded · 1.1% → 1.4%+16,651,580 shares
- Alphabet~$3.30BAdded · 2.3% → 2.6%+11,465,200 shares
- Western Digital~$2.93BAdded · 0.0% → 0.4%+10,816,431 shares
- Northrop Grumman~$2.36BAdded · 0.3% → 0.6%+3,458,109 shares
- Amgen~$2.18BAdded · 1.0% → 1.4%+6,190,632 shares
- AT&T~$1.86BAdded · 0.2% → 0.4%+64,066,995 shares
- TSMC~$1.85BAdded · 1.1% → 1.5%+5,482,648 shares
Largest sells
Since Q4 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Micron~$5.47BCut · 2.3% → 1.9%−16,194,733 shares
- Synopsys~$3.12BSold out · 0.4% → 0.0%−6,635,080 shares
- Cloudflare~$2.70BCut · 1.0% → 0.6%−13,089,948 shares
- Broadcom~$2.19BCut · 5.8% → 4.9%−7,068,689 shares
- Thermo Fisher Scientific~$2.14BCut · 0.9% → 0.4%−4,357,498 shares
- Quanta Services~$2.05BCut · 0.3% → 0.2%−3,731,933 shares
- Costco~$1.90BCut · 0.5% → 0.3%−1,903,121 shares
- Alnylam Pharmaceuticals Inc~$1.82BCut · 0.9% → 0.5%−5,499,424 shares
- Shopify~$1.68BCut · 1.0% → 0.5%−14,125,861 shares
- GE Aerospace~$1.67BCut · 0.9% → 0.6%−5,874,569 shares
Holdings
As of Mar 31, 2026. Changes are in shares against Dec 31, 2025, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BroadcomCOM · shares −5.7% · price −10.6% | 4.9% | $35.96B | −$4.26B | ||||||||
| MetaCL A · shares +3.8% · price −13.3% | 3.2% | $23.49B | −$3.48B | ||||||||
| MicrosoftCOM · shares −4.2% · price −23.5% | 3.1% | $22.85B | −$7.01B | ||||||||
| NvidiaCOM · shares −0.4% · price −6.5% | 3.1% | $22.72B | −$1.58B | ||||||||
| Philip Morris InternationalCOM · shares +0.8% · price +3.1% | 3.0% | $22.06B | +$653.2M | ||||||||
| AlphabetCAP STK CL A · shares +21% · price −8.1% | 2.6% | $18.79B | −$1.37B | ||||||||
| TeslaCOM · shares +1.0% · price −17.3% | 2.2% | $15.95B | −$3.31B | ||||||||
| Eli LillyCOM · shares +3.9% · price −14.4% | 2.0% | $14.37B | −$2.33B | ||||||||
| MicronCOM · shares −28% · price +18.4% | 1.9% | $14.21B | +$2.20B | ||||||||
| AlphabetCAP STK CL C · shares +55% · price −8.6% | 1.8% | $12.84B | −$777.7M | ||||||||
| Vertex PharmaceuticalsCOM · shares −0.6% · price −1.5% | 1.5% | $11.33B | −$173.1M | ||||||||
| TSMCSPONSORED ADS · shares +20% · price +11.2% | 1.5% | $11.11B | +$930.6M | ||||||||
| AmazonCOM · shares +49% · price −9.8% | 1.4% | $10.50B | −$762.3M | ||||||||
| AmgenCOM · shares +27% · price +7.5% | 1.4% | $10.30B | +$566.4M | ||||||||
| Canadian Nat Res Ltd Med TerCOM · shares −1.1% · price +44.0% | 1.3% | $9.64B | +$2.95B | ||||||||
| NetflixCOM · shares +11% · price +2.5% | 1.3% | $9.53B | +$213.1M | ||||||||
| StarbucksCOM · shares +22% · price +6.4% | 1.3% | $9.26B | +$454.7M | ||||||||
| Visa Inc.COM CL A · shares +2.9% · price −13.8% | 1.0% | $7.61B | −$1.19B | ||||||||
| UnitedHealth GroupCOM · shares +23% · price −18.0% | 1.0% | $7.52B | −$1.35B | ||||||||
| EOG ResourcesCOM · shares +28% · price +37.7% | 1.0% | $7.50B | +$1.61B | ||||||||
| Bank of AmericaCOM · shares +2.1% · price −11.4% | 0.96% | $7.03B | −$885.0M | ||||||||
| Deere & CompanyCOM · shares +28% · price +21.0% | 0.94% | $6.91B | +$937.0M | ||||||||
| AppleCOM · shares −1.3% · price −6.7% | 0.94% | $6.89B | −$492.1M | ||||||||
| Union Pacific CorporationCOM · shares +34% · price +4.9% | 0.90% | $6.57B | +$227.0M | ||||||||
| KLACOM NEW · shares +12% · price +21.1% | 0.82% | $6.01B | +$936.9M | ||||||||
| Total · 620 positions | 100% | $732.94B | −$27.96B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2025 to Q1 2026: 503 stocks held throughout, down $27.96B (−4.2%).
- Canadian Nat Res Ltd Med Ter+$2.95B+44%
- Micron+$2.20B+18%
- EOG Resources+$1.61B+38%
- Deere & Company+$937.0M+21%
- KLA+$936.9M+21%
- Eli Lilly−$2.33B−14%
- Tesla−$3.31B−17%
- Meta−$3.48B−13%
- Broadcom−$4.26B−11%
- Microsoft−$7.01B−23%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $846.43B+15% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $732.94B−0% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $735.30B+0% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $732.04B+6% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $687.95B+11% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $617.20B−6% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $658.71B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $645.05B+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $613.27B+1% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $604.23B+7% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $562.26B+11% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $504.81B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $519.91B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $483.79B+3% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $469.11B+5% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $445.41B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $470.72B−19% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $580.76B−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $632.21B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $585.85B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $588.43B+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $541.07B+4% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $518.94B+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $456.91B+11% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $413.27B+20% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $344.62B−23% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $447.39B+8% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $415.21B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $426.29B+3% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $412.39B+12% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $369.11B−10% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $411.05B−12% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $467.29B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $444.21B−4% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $461.25B+4% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $441.49B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $425.76B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $418.31B+5% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $397.60B+3% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $384.55B+4% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $370.85B+2% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $361.93B | SEC ↗ |